REFERENCES
- Chintagumpala M, Chevez-Barrios P, Paysse EA, Retinoblastoma: review of current management. The Oncologist. 2007;12(10):1237–1246.
- Kim JW, Abramson DH, Dunkel IJ. Current management strategies for intraocular retinoblastoma. Drugs. 2007;67(15):2173–2185.
- MacCarthy A, Birch JM, Draper GJ, Retinoblastoma in great britain 1963–2002. Br J Ophthalmol. 2008.
- Chantada GL, Fandiño AC, Guitter MR, Results of a prospective study for the treatment of unilateral retinoblastoma. Pediatr Blood Cancer. 2010;55(1):60–66.
- Antoneli CBG, Steinhorst F, Ribeiro K de CB, The Pediatrician's ability to recognize the presenting signs and symptoms of retinoblastoma. Revista da Associação Médica Brasileira. 2004;50(4):400–402.
- Chantada GL, Gonzalez A, Fandino A, Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma. J Pediatr Hematol Oncol. 2009;31(5):325–329.
- Bai S, Ren R, Li B, Delay in the diagnosis of retinoblastoma in China. Acta Ophthalmologica. 2011;89(1):e72–e74.
- Rodriguez-Galindo C, Wilson MW, Chantada G, Retinoblastoma: one world, one vision. Pediatrics. 2008;122(3):e763–e770.
- Chung SE, Sa HS, Koo HH, Clinical manifestations and treatment of retinoblastoma in Korea. Br J Ophthalmol. 2008;92(9):1180–1184.
- Abramson DH, Dunkel IJ, Brodie SE, Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117(8):1623–1629.
- Abramson DH, Beaverson K, Sangani P, Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics. 2003;112(6 Pt 1):1248–1255.
- Abramson DH, Gobin YP, Marr BP, Intra-arterial chemotherapy for retinoblastoma. Ophthalmology. 2012;119(8):1720–1721.
- Palioura S, Gobin YP, Brodie SE, Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment. Pediatr Blood & Cancer. 2012; 59(5):859–864.
- Suzuki S, Yamane T, Mohri M, Kaneko A. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology. 2011;118(10):2081–2087.
- Marr BP, Brodie SE, Dunkel IJ, Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan, and melphalan for intraocular retinoblastoma: preliminary results. Br J Ophthalmol. 2012;96(10):1300–1303.
- Jabbour P, Chalouhi N, Tjoumakaris S, Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr. 2012;10(3):175–181.
- Rodriguez-Galindo C. The basics of retinoblastoma: back to school. Pediatr Blood Cancer. 2011;57(7):1093–1094.
- Team RDC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
- MacCarthy A, Birch JM, Draper GJ, Retinoblastoma: treatment and survival in great britain 1963 to 2002. Br J Ophthalmol. 2009;93(1):38–39.
- Bonanomi MTBC, Almeida MTA de, Cristofani LM, Odone Filho V. Retinoblastoma: a three-year-study at a Brazilian medical school hospital. Clinics. 2009;64(5):427–434.
- Wallach M, Balmer A, Munier F, Shorter time to diagnosis and improved stage at presentation in Swiss patients with retinoblastoma treated from 1963 to 2004. Pediatrics. 2006;118(5):e1493–e1498.
- Alvarado-Castillo B, Campos-Campos LE, Villavicencio-Torres A. Clinical and metastatic characteristics in retinoblastoma. Rev Med Inst Mex Seguro Soc. 2009;47(2):151–156.
- Butros LJ, Abramson DH, Dunkel IJ. Delayed diagnosis of retinoblastoma: analysis of degree, cause, and potential consequences. Pediatrics. 2002;109(3):E45.
- Section on Ophthalmology. Red reflex examination in infants. AAP Policy. 2002;109(5):980.
- Imhof SM, Moll AC, Schouten-van Meeteren AYN. Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands. Br J Ophthalmol. 2006;90(7):875–878.